FIELD: medicine. SUBSTANCE: method involves additionally administering aspirin and Aevit in addition to combined helium-neon laser therapy and medical drug treatment, daily during the whole treatment course. Antithrombin III value (AT III) and the level of general antioxidation activity in blood are controlled (before and after helium-neon laser therapy). The value of AT III being lowered with respect to norm, helium-neon laser therapy is applied each second-third day and every day in other cases. Maximum values of antioxidation activity being stabilized, intravenous injections are finished and skin procedures are started. The procedures are applied every day or every second day during 30-45 s on each stimulation zone. EFFECT: enhanced effectiveness of treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING ACUTE AND CHRONIC NONSPECIFIC PULMONARY DISEASES | 1993 |
|
RU2088281C1 |
| METHOD FOR CURING STENOCARDIA | 0 |
|
SU1766425A1 |
| METHOD OF TREATING ISCHEMIC DISEASE | 0 |
|
SU1473771A1 |
| METHOD FOR DETERMINING DURATION OF TREATMENT COURSE OF INTRAVENOUS HELIUM-NEON LASER THERAPY | 0 |
|
SU1734015A1 |
| METHOD FOR CORRECTING LASER THERAPY COMPLICATIONS IN TREATING MYOCARDIAL ISCHEMIA DISEASE | 1992 |
|
RU2042353C1 |
| METHOD FOR TREATING THE EMERGENCY STATES IN THE MENTAL DISEASE CASES | 0 |
|
SU1697738A1 |
| METHOD FOR TREATMENT OF HYPERLIPOIDEMIA, HYPERCOAGULATION, PEROXIDATION SYNDROMES | 2001 |
|
RU2195347C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC PANCREATITIS | 2008 |
|
RU2387473C1 |
| METHOD FOR TREATING PATIENTS WITH GASTRIC AND DUODENAL ULCEROUS DISEASE | 2003 |
|
RU2254889C1 |
| METHOD FOR DETERMINATION OF INDIVIDUAL SENSITIVITY TO LASER THERAPY AT PATIENTS HAVING CARDIAC ISCHEMIA | 1992 |
|
RU2031408C1 |
